A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas

Clinical trial NCT04390802 · UNKNOWN

Trial details

NCT number: NCT04390802
Sponsor: Massachusetts General Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Pituitary Adenoma

Start date: 2021-07-01
Primary completion: 2021-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.